Skip to main content

Table 3 Cause of death of 45 patients with rheumatic disease and cancer

From: Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis

  RD Cancer Cause of death Stage ECOGa Comorbidityb
1 DM/PM Breast Cancer progression 2 1 1
2 DM/PM Gastric Cancer progression 4 0 0
3 DM/PM Lung Cancer progression 1 0 0
4 DM/PM Lung Cancer progression 1 0 1
5 DM/PM Lung Cancer progression 2 2 1
6 DM/PM Lung Cancer progression 2 2 0
7 DM/PM Lung Cancer progression 3 2 0
8 DM/PM Lung Cancer progression NA 0 0
9 RA Breast Cancer progression 2 0 2
10 RA Breast Cancer progression 4 1 0
11 RA Breast Congestive Heart failure 1 0 1
12 RA Breast Old age 2 0 2
13 RA Colon Cancer progression 1 1 1
14 RA Colon Cancer progression 3 2 2
15 RA Colon Cancer progression 4 1 2
16 RA Lung Cancer progression 1 0 0
17 RA Lung Cancer progression 1 0 0
18 RA Lung Cancer progression 1 0 0
19 RA Lung Cancer progression 2 1 2
20 RA Lung Cancer progression 2 0 0
21 RA Lung Cancer progression 2 0 1
22 RA Lung Cancer progression 3 2 1
23 RA Lung Cancer progression 3 0 1
24 RA Lung Cancer progression 3 0 1
25 RA Lung Cancer progression 3 1 2
26 RA Lung Cancer progression 4 1 0
27 RA Lung Cancer progression 4 2 0
28 RA Lung Cancer progression 4 0 0
29 RA Lung Cancer progression 4 1 1
30 RA Lung Cancer progression 4 2 2
31 RA Lung Cancer progression 4 2 1
32 RA Lung Cancer progression 4 1 0
33 RA Lung Cancer progression 4 2 1
34 RA Lung Cancer progression 4 0 0
35 RA Lung Cancer progression 4 1 0
36 RA Lung Cancer progression 4 0 2
37 RA Lung Cancer progression NA 1 0
38 SLE Breast Cancer progression 4 1 0
39 SLE Colon Cancer progression 1 0 2
40 SSc Colon ILD aggrevation 3 1 2
41 SSc Lung Cancer progression 4 1 2
42 SSc Lung Cancer progression 4 2 1
43 SSc Lung Cancer progression 4 1 0
44 SSc Lung Cancer progression 4 0 0
45 SSc Lung Cancer progression NA 2 2
  1. F female, NA not available, RD rheumatic disease, DM dermatomyositis, PM polymyositis, RA rheumatoid arthritis, SLE systemic lupus erythematosus, SSc systemic sclerosis
  2. aAn Eastern Cooperative Oncology Group (ECOG) performance status
  3. bThe Charlson comorbidity index was adjusted for connective tissue disease and cancer